RAN and neuroblastoma: Experimental treatment of neuroblastoma cells with 1 μm oligomeric Aβ42 corroborated our hypothesis that amyloid is involved in reduced expression of RAN and consequent aberrant cytoplasmic sequestering of DNMT1 and RNA pol II.